Correlation Between Taro Pharmaceutical and Evoke Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Taro Pharmaceutical and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taro Pharmaceutical and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taro Pharmaceutical Industries and Evoke Pharma, you can compare the effects of market volatilities on Taro Pharmaceutical and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taro Pharmaceutical with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taro Pharmaceutical and Evoke Pharma.

Diversification Opportunities for Taro Pharmaceutical and Evoke Pharma

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Taro and Evoke is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Taro Pharmaceutical Industries and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Taro Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taro Pharmaceutical Industries are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Taro Pharmaceutical i.e., Taro Pharmaceutical and Evoke Pharma go up and down completely randomly.

Pair Corralation between Taro Pharmaceutical and Evoke Pharma

If you would invest  4,297  in Taro Pharmaceutical Industries on August 27, 2024 and sell it today you would earn a total of  0.00  from holding Taro Pharmaceutical Industries or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.76%
ValuesDaily Returns

Taro Pharmaceutical Industries  vs.  Evoke Pharma

 Performance 
       Timeline  
Taro Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taro Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taro Pharmaceutical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Evoke Pharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Evoke Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Evoke Pharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Taro Pharmaceutical and Evoke Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Taro Pharmaceutical and Evoke Pharma

The main advantage of trading using opposite Taro Pharmaceutical and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taro Pharmaceutical position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.
The idea behind Taro Pharmaceutical Industries and Evoke Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum